BCG C. diff vaccine

The BCG C. diff vaccine is designed to protect against infections caused by Clostridium difficile, a bacteria that can cause severe diarrhea and colitis, especially in hospitalized or antibiotic-treated patients. Although BCG is traditionally a vaccine for tuberculosis, current research explores its potential to boost the immune system’s ability to fight C. difficile infections. The goal is to prevent or lessen the severity of these infections, reducing illness and healthcare costs. However, this vaccine is still under investigation, and more studies are needed to confirm its safety and effectiveness for C. difficile prevention.